Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1808 | 6256 | 40.4 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
385 | 3 | MICROGLIA//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM | 31368 |
1808 | 2 | LITHIUM//GLYCOGEN SYNTHASE KINASE 3//GSK 3 | 6256 |
3883 | 1 | GLYCOGEN SYNTHASE KINASE 3//GSK 3//GLYCOGEN SYNTHASE KINASE 3 BETA | 1887 |
7705 | 1 | LITHIUM INTOXICATION//LITHIUM//LITHIUM TOXICITY | 1337 |
8695 | 1 | LITHIUM//IST SCI HSR//MOL NEUROPSYCHOPHARMACOL PROGRAM | 1227 |
19697 | 1 | 4C4//BLOOD LITHIUM//REPROD ENDOCRINE PHYSIOL | 493 |
22828 | 1 | LITHIUM CLEARANCE//SNGFR//GLOMERULO TUBULAR BALANCE | 367 |
25868 | 1 | SEROTONIN 5 HT SYNDROME//CATALEPSIA//CENTRAL 5 HT1A RECEPTOR | 269 |
25904 | 1 | MOOD DISORDERS PROGRAMMED 1//PROGRAM HLTH SCIHLTH SCI UNIT//AGRN | 268 |
30540 | 1 | LITHIUM EXPOSURE//LITHIUM LOW PROTEIN DIET//MINING WASTE WATERS | 167 |
33524 | 1 | BIOINORGAN INORGAN DRUG CHEM//TRANSMEMBRANE BEHAVIOR//CESIUM 5 SULFOSALICYLATE | 123 |
33927 | 1 | TURN ALTERNATION//AVOIDANCE FEAR//BRAIN DAMAGE RECOVERY | 118 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LITHIUM | authKW | 769412 | 16% | 16% | 1012 |
2 | GLYCOGEN SYNTHASE KINASE 3 | authKW | 361223 | 3% | 40% | 186 |
3 | GSK 3 | authKW | 253086 | 2% | 37% | 141 |
4 | GLYCOGEN SYNTHASE KINASE 3 BETA | authKW | 196600 | 2% | 27% | 148 |
5 | GSK 3 BETA | authKW | 135812 | 2% | 21% | 132 |
6 | GSK 3 INHIBITORS | authKW | 95586 | 0% | 85% | 23 |
7 | LITHIUM INTOXICATION | authKW | 93668 | 0% | 80% | 24 |
8 | GLYCOGEN SYNTHASE KINASE 3 GSK 3 | authKW | 68919 | 0% | 46% | 31 |
9 | GSK3 BETA | authKW | 62896 | 1% | 17% | 77 |
10 | BIPOLAR DISORDER | authKW | 62373 | 6% | 4% | 346 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 32586 | 26% | 0% | 1656 |
2 | Neurosciences | 13371 | 28% | 0% | 1766 |
3 | Pharmacology & Pharmacy | 8610 | 23% | 0% | 1460 |
4 | Clinical Neurology | 1946 | 9% | 0% | 571 |
5 | Biochemistry & Molecular Biology | 641 | 13% | 0% | 815 |
6 | Behavioral Sciences | 540 | 3% | 0% | 160 |
7 | Psychology | 500 | 2% | 0% | 152 |
8 | Medicine, Research & Experimental | 458 | 4% | 0% | 275 |
9 | Chemistry, Medicinal | 340 | 3% | 0% | 186 |
10 | Toxicology | 334 | 3% | 0% | 187 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PSYCHIAT BEHAV NEUROBIOL | 46787 | 1% | 14% | 68 |
2 | MOL NEUROBIOL SECT | 36706 | 1% | 21% | 36 |
3 | SPARKS 1057 | 35405 | 0% | 52% | 14 |
4 | MOL PATHOPHYSIOL | 31237 | 1% | 13% | 49 |
5 | IST SCI HSR | 29274 | 0% | 100% | 6 |
6 | EXPT MED NEPHROL CRIT CARE MED | 24395 | 0% | 100% | 5 |
7 | MOL NEUROPSYCHOPHARMACOL PROGRAM | 19516 | 0% | 100% | 4 |
8 | DIAVERUM RENAL SERV GRP | 14637 | 0% | 100% | 3 |
9 | SPARKS | 14055 | 0% | 41% | 7 |
10 | CELLULAR MOL PATHOPHYSIOL | 14041 | 0% | 21% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOLOGICAL PSYCHIATRY | 13749 | 3% | 2% | 161 |
2 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 9220 | 2% | 2% | 97 |
3 | BIPOLAR DISORDERS | 8068 | 1% | 4% | 47 |
4 | NEUROPSYCHOBIOLOGY | 7793 | 1% | 3% | 62 |
5 | INTERNATIONAL PHARMACOPSYCHIATRY | 6424 | 0% | 11% | 12 |
6 | JOURNAL OF TRACE AND MICROPROBE TECHNIQUES | 5568 | 0% | 5% | 25 |
7 | PHARMACOPSYCHIATRY | 5525 | 1% | 2% | 48 |
8 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 5359 | 1% | 2% | 55 |
9 | PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE | 4274 | 0% | 15% | 6 |
10 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 4141 | 1% | 2% | 39 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LITHIUM | 769412 | 16% | 16% | 1012 | Search LITHIUM | Search LITHIUM |
2 | GLYCOGEN SYNTHASE KINASE 3 | 361223 | 3% | 40% | 186 | Search GLYCOGEN+SYNTHASE+KINASE+3 | Search GLYCOGEN+SYNTHASE+KINASE+3 |
3 | GSK 3 | 253086 | 2% | 37% | 141 | Search GSK+3 | Search GSK+3 |
4 | GLYCOGEN SYNTHASE KINASE 3 BETA | 196600 | 2% | 27% | 148 | Search GLYCOGEN+SYNTHASE+KINASE+3+BETA | Search GLYCOGEN+SYNTHASE+KINASE+3+BETA |
5 | GSK 3 BETA | 135812 | 2% | 21% | 132 | Search GSK+3+BETA | Search GSK+3+BETA |
6 | GSK 3 INHIBITORS | 95586 | 0% | 85% | 23 | Search GSK+3+INHIBITORS | Search GSK+3+INHIBITORS |
7 | LITHIUM INTOXICATION | 93668 | 0% | 80% | 24 | Search LITHIUM+INTOXICATION | Search LITHIUM+INTOXICATION |
8 | GLYCOGEN SYNTHASE KINASE 3 GSK 3 | 68919 | 0% | 46% | 31 | Search GLYCOGEN+SYNTHASE+KINASE+3+GSK+3 | Search GLYCOGEN+SYNTHASE+KINASE+3+GSK+3 |
9 | GSK3 BETA | 62896 | 1% | 17% | 77 | Search GSK3+BETA | Search GSK3+BETA |
10 | BIPOLAR DISORDER | 62373 | 6% | 4% | 346 | Search BIPOLAR+DISORDER | Search BIPOLAR+DISORDER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BEUREL, E , GRIECO, SF , JOPE, RS , (2015) GLYCOGEN SYNTHASE KINASE-3 (GSK3): REGULATION, ACTIONS, AND DISEASES.PHARMACOLOGY & THERAPEUTICS. VOL. 148. ISSUE . P. 114 -131 | 165 | 57% | 61 |
2 | LI, XH , JOPE, RS , (2010) IS GLYCOGEN SYNTHASE KINASE-3 A CENTRAL MODULATOR IN MOOD REGULATION?.NEUROPSYCHOPHARMACOLOGY. VOL. 35. ISSUE 11. P. 2143-2154 | 111 | 62% | 123 |
3 | O'LEARY, O , NOLAN, Y , (2015) GLYCOGEN SYNTHASE KINASE-3 AS A THERAPEUTIC TARGET FOR COGNITIVE DYSFUNCTION IN NEUROPSYCHIATRIC DISORDERS.CNS DRUGS. VOL. 29. ISSUE 1. P. 1 -15 | 114 | 63% | 7 |
4 | ELDAR-FINKELMAN, H , MARTINEZ, A , (2011) GSK-3 INHIBITORS: PRECLINICAL AND CLINICAL FOCUS ON CNS.FRONTIERS IN MOLECULAR NEUROSCIENCE. VOL. 4. ISSUE . P. - | 118 | 59% | 71 |
5 | MAQBOOL, M , MOBASHIR, M , HODA, N , (2016) PIVOTAL ROLE OF GLYCOGEN SYNTHASE KINASE-3: A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 107. ISSUE . P. 63 -81 | 80 | 50% | 11 |
6 | RAYASAM, GV , TULASI, VK , SODHI, R , DAVIS, JA , RAY, A , (2009) GLYCOGEN SYNTHASE KINASE 3: MORE THAN A NAMESAKE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 156. ISSUE 6. P. 885 -898 | 83 | 62% | 225 |
7 | ARFEEN, M , BHARATAM, PV , (2013) DESIGN OF GLYCOGEN SYNTHASE KINASE-3 INHIBITORS: AN OVERVIEW ON RECENT ADVANCEMENTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 26. P. 4755 -4775 | 104 | 63% | 9 |
8 | FOUNTOULAKIS, KN , VIETA, E , BOURAS, C , NOTARIDIS, G , GIANNAKOPOULOS, P , KAPRINIS, G , AKISKAL, H , (2008) A SYSTEMATIC REVIEW OF EXISTING DATA ON LONG-TERM LITHIUM THERAPY: NEUROPROTECTIVE OR NEUROTOXIC?.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. VOL. 11. ISSUE 2. P. 269 -287 | 104 | 68% | 31 |
9 | PANDEY, MK , DEGRADO, TR , (2016) GLYCOGEN SYNTHASE KINASE-3 (GSK-3)-TARGETED THERAPY AND IMAGING.THERANOSTICS. VOL. 6. ISSUE 4. P. 571 -593 | 81 | 63% | 3 |
10 | DECKER, BS , GOLDFARB, DS , DARGAN, PI , FRIESEN, M , GOSSELIN, S , HOFFMAN, RS , LAVERGNE, V , NOLIN, TD , GHANNOUM, M , (2015) EXTRACORPOREAL TREATMENT FOR LITHIUM POISONING: SYSTEMATIC REVIEW AND RECOMMENDATIONS FROM THE EXTRIP WORKGROUP.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 10. ISSUE 5. P. 875 -887 | 79 | 71% | 6 |
Classes with closest relation at Level 2 |